51 related articles for article (PubMed ID: 35591845)
1. Retraction Note: The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Zhang L; Yang L; Xia ZW; Yang SC; Li WH; Liu B; Yu ZQ; Gong PF; Yang YL; Sun WZ; Mo J; Li GS; Wang TY; Wang K
Clin Exp Med; 2023 Dec; 23(8):5481. PubMed ID: 37847470
[No Abstract] [Full Text] [Related]
2. TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer.
Ma JJ; Xiang C; Wang JW
Aging (Albany NY); 2023 Oct; 15(19):10607-10626. PubMed ID: 37815894
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosine picked threonine kinase stimulates proliferation of human osteosarcoma cells
Wang ZX; Ren SC; Ren J
Arch Med Sci; 2022; 18(3):775-785. PubMed ID: 35591845
[TBL] [Abstract][Full Text] [Related]
4. TTK contributes to tumor growth and metastasis of clear cell renal cell carcinoma by inducing cell proliferation and invasion.
Liu XD; Yao DW; Xin F
Neoplasma; 2019 Nov; 66(6):946-953. PubMed ID: 31607131
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract][Full Text] [Related]
6. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
Wang ZX; Ren SC; Chang ZS; Ren J
Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
[TBL] [Abstract][Full Text] [Related]
7. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
8. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of in-hospital treatment of cardiac patients who survived cardiac arrest and experienced coronary angiography.
Barauskas M; Unikas R; Žiubrytė G
Arch Med Sci Atheroscler Dis; 2018; 3():e1-e7. PubMed ID: 30775583
[TBL] [Abstract][Full Text] [Related]
10. Cancer statistics, 2019.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation.
Yang M; Zhang L; Wang X; Zhou Y; Wu S
Arch Med Sci; 2018 Oct; 14(6):1333-1339. PubMed ID: 30393487
[TBL] [Abstract][Full Text] [Related]
12. TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer.
King JL; Zhang B; Li Y; Li KP; Ni JJ; Saavedra HI; Dong JT
Oncogenesis; 2018 Sep; 7(9):69. PubMed ID: 30206215
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, awareness, treatment and control of hypertension in the adult Polish population - Multi-center National Population Health Examination Surveys - WOBASZ studies.
Niklas A; Flotyńska A; Puch-Walczak A; Polakowska M; Topór-Mądry R; Polak M; Piotrowski W; Kwaśniewska M; Nadrowski P; Pająk A; Bielecki W; Kozakiewicz K; Drygas W; Zdrojewski T; Tykarski A;
Arch Med Sci; 2018 Aug; 14(5):951-961. PubMed ID: 30154875
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
